Cargando…
CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients
Olanzapine is a commonly prescribed atypical antipsychotic agent for treatment of patients with schizophrenia and bipolar disorders. Previous in vitro studies using human liver microsomes identified CYP1A2 and CYP2D6 enzymes being responsible for CYP-mediated metabolism of olanzapine. The present wo...
Autores principales: | Fekete, Ferenc, Menus, Ádám, Tóth, Katalin, Kiss, Ádám Ferenc, Minus, Annamária, Sirok, Dávid, Belič, Aleš, Póti, Ádám, Csukly, Gábor, Monostory, Katalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613299/ https://www.ncbi.nlm.nih.gov/pubmed/37898643 http://dx.doi.org/10.1038/s41598-023-45752-6 |
Ejemplares similares
-
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia
por: Menus, Ádám, et al.
Publicado: (2020) -
Potential Role of Patients’ CYP3A-Status in Clozapine Pharmacokinetics
por: Tóth, Katalin, et al.
Publicado: (2017) -
Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype
por: Tóth, Katalin, et al.
Publicado: (2016) -
CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity
por: Fekete, Ferenc, et al.
Publicado: (2022) -
CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function
por: Mangó, Katalin, et al.
Publicado: (2022)